Insulin therapy protects the central and peripheral nervous system of intensive care patients

By G. V. D. Berghe, K. Schoonheydt, P. Becx, F. Bruyninckx, P. Wouters. Neurology, 2005

655 citations recorded by the source corpus.

Subfields: Critical Care and Intensive Care Medicine, Endocrinology, Diabetes and Metabolism, Neurology

View Paper: https://www.semanticscholar.org/paper/5fb69a1f41b788917f69806562aa55c4491b5758

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. D. Needham

Citations in the corpus

• BRAIN FUEL METABOLISM, AGING AND ALZHEIMER’S DISEASE (2010, background): “Given acutely, insulin has positive effects on memory and learning but these effects seem to reverse and become detrimental during chronic insulin treatment [81,86].”
• In-hospital cardiac arrest: incidence, prognosis and possible measures to improve survival (2007, methodology): “1 mmol/l or 80–110 mg/dl) using insulin reduces hospital mortality [78] and may protect the central and peripheral nervous system of critically ill adults [79], but this has not been demonstrated in post-cardiac arrest patients specifically.”
• Acquired weakness, handgrip strength, and mortality in critically ill patients. (2008, background): “Several strategies have been developed to prevent ICUAP (17, 35), but few studies have explored the treatment of clinically evident disease.”
• Long-term complications of critical care (2011, background): “Intensive insulin therapy targeting tight glucose control has reduced some electromyographic evidence of muscle abnormality (42, 43).”